Global Chorionic Gonadotropin for Injection Market Growth 2025-2031

Publication ID:

LPI02257175

Publication Date:

March 3, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Chorionic Gonadotropin for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.
United States market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Chorionic Gonadotropin for Injection players cover Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淐horionic Gonadotropin for Injection Industry Forecast鈥� looks at past sales and reviews total world Chorionic Gonadotropin for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Chorionic Gonadotropin for Injection sales for 2025 through 2031. With Chorionic Gonadotropin for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chorionic Gonadotropin for Injection industry.
This Insight Report provides a comprehensive analysis of the global Chorionic Gonadotropin for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chorionic Gonadotropin for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Chorionic Gonadotropin for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chorionic Gonadotropin for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chorionic Gonadotropin for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Chorionic Gonadotropin for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
u-hCG
r-hCG
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Shanghai Livzon Pharmaceutical Co., Ltd.
Qingdao Guanlong Biopharmaceutical Co., Ltd.
Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
Ningbo Renjian Pharmaceutical Group Co., Ltd.
Merck
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chorionic Gonadotropin for Injection market?
What factors are driving Chorionic Gonadotropin for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chorionic Gonadotropin for Injection market opportunities vary by end market size?
How does Chorionic Gonadotropin for Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chorionic Gonadotropin for Injection Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Country/Region, 2020, 2024 & 2031
2.2 Chorionic Gonadotropin for Injection Segment by Type
2.2.1 u-hCG
2.2.2 r-hCG
2.3 Chorionic Gonadotropin for Injection Sales by Type
2.3.1 Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2020-2025)
2.3.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Type (2020-2025)
2.3.3 Global Chorionic Gonadotropin for Injection Sale Price by Type (2020-2025)
2.4 Chorionic Gonadotropin for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Chorionic Gonadotropin for Injection Sales by Application
2.5.1 Global Chorionic Gonadotropin for Injection Sale Market Share by Application (2020-2025)
2.5.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Application (2020-2025)
2.5.3 Global Chorionic Gonadotropin for Injection Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Chorionic Gonadotropin for Injection Breakdown Data by Company
3.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Company (2020-2025)
3.1.2 Global Chorionic Gonadotropin for Injection Sales Market Share by Company (2020-2025)
3.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Company (2020-2025)
3.2.1 Global Chorionic Gonadotropin for Injection Revenue by Company (2020-2025)
3.2.2 Global Chorionic Gonadotropin for Injection Revenue Market Share by Company (2020-2025)
3.3 Global Chorionic Gonadotropin for Injection Sale Price by Company
3.4 Key Manufacturers Chorionic Gonadotropin for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chorionic Gonadotropin for Injection Product Location Distribution
3.4.2 Players Chorionic Gonadotropin for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Chorionic Gonadotropin for Injection by Geographic Region
4.1 World Historic Chorionic Gonadotropin for Injection Market Size by Geographic Region (2020-2025)
4.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chorionic Gonadotropin for Injection Market Size by Country/Region (2020-2025)
4.2.1 Global Chorionic Gonadotropin for Injection Annual Sales by Country/Region (2020-2025)
4.2.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chorionic Gonadotropin for Injection Sales Growth
4.4 APAC Chorionic Gonadotropin for Injection Sales Growth
4.5 Europe Chorionic Gonadotropin for Injection Sales Growth
4.6 Middle East & Africa Chorionic Gonadotropin for Injection Sales Growth
5 Americas
5.1 Americas Chorionic Gonadotropin for Injection Sales by Country
5.1.1 Americas Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
5.1.2 Americas Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
5.2 Americas Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
5.3 Americas Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chorionic Gonadotropin for Injection Sales by Region
6.1.1 APAC Chorionic Gonadotropin for Injection Sales by Region (2020-2025)
6.1.2 APAC Chorionic Gonadotropin for Injection Revenue by Region (2020-2025)
6.2 APAC Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
6.3 APAC Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chorionic Gonadotropin for Injection by Country
7.1.1 Europe Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
7.1.2 Europe Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
7.2 Europe Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
7.3 Europe Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chorionic Gonadotropin for Injection by Country
8.1.1 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
8.1.2 Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotropin for Injection
10.3 Manufacturing Process Analysis of Chorionic Gonadotropin for Injection
10.4 Industry Chain Structure of Chorionic Gonadotropin for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chorionic Gonadotropin for Injection Distributors
11.3 Chorionic Gonadotropin for Injection Customer
12 World Forecast Review for Chorionic Gonadotropin for Injection by Geographic Region
12.1 Global Chorionic Gonadotropin for Injection Market Size Forecast by Region
12.1.1 Global Chorionic Gonadotropin for Injection Forecast by Region (2026-2031)
12.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chorionic Gonadotropin for Injection Forecast by Type (2026-2031)
12.7 Global Chorionic Gonadotropin for Injection Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Shanghai Livzon Pharmaceutical Co., Ltd.
13.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
13.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
13.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Main Business Overview
13.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
13.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
13.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Company Information
13.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
13.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Main Business Overview
13.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Latest Developments
13.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
13.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Company Information
13.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
13.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Main Business Overview
13.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Latest Developments
13.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
13.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Information
13.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
13.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Main Business Overview
13.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Chorionic Gonadotropin for Injection Product Portfolios and Specifications
13.5.3 Merck Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂